Ronenn Roubenoff
Overview
Explore the profile of Ronenn Roubenoff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
132
Citations
7004
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Johns N, Hatakeyama S, Stephens N, Degen M, Degen S, Frieauff W, et al.
PLoS One
. 2024 Dec;
19(12):e0314953.
PMID: 39621792
[This corrects the article DOI: 10.1371/journal.pone.0083618.].
2.
Evans W, Guralnik J, Cawthon P, Appleby J, Landi F, Clarke L, et al.
Geroscience
. 2023 Nov;
46(1):183-190.
PMID: 37996722
In addition to the role of skeletal muscle in movement and locomotion, muscle plays a critical role in a broad array of metabolic processes that can contribute to improved health...
3.
GomezMancilla B, Meriggioli M, Genge A, Roubenoff R, Espie P, Dupuy C, et al.
J Clin Neurosci
. 2023 Nov;
119:76-84.
PMID: 37988976
Background: Increased morbidity in many patients with myasthenia gravis (MG) on long-term immunosuppression highlights the need for improved treatments. The aim of this study is to investigate the safety and...
4.
5.
Petricoul O, Nazarian A, Schuehly U, Schramm U, David O, Laurent D, et al.
Clin Pharmacokinet
. 2022 Dec;
62(1):141-155.
PMID: 36527600
Background: Bimagrumab is a human monoclonal antibody binding to the activin type II receptor with therapeutic potential in conditions of muscle wasting and obesity. This phase I study evaluated the...
6.
Gerwin N, Scotti C, Halleux C, Fornaro M, Elliott J, Zhang Y, et al.
Nat Med
. 2022 Dec;
28(12):2633-2645.
PMID: 36456835
Osteoarthritis (OA) is a common, debilitating, chronic disease with no disease-modifying drug approved to date. We discovered LNA043-a derivative of angiopoietin-like 3 (ANGPTL3)-as a potent chondrogenesis inducer using a phenotypic...
7.
Demanse D, Saxer F, Lustenberger P, Tanko L, Nikolaus P, Rasin I, et al.
Semin Arthritis Rheum
. 2022 Nov;
58:152140.
PMID: 36446256
Objectives: Osteoarthritis (OA) is a complex disease comprising diverse underlying patho-mechanisms. To enable the development of effective therapies, segmentation of the heterogenous patient population is critical. This study aimed at...
8.
Laurent D, Riek J, Sinclair C, Houston P, Roubenoff R, Papanicolaou D, et al.
Neurology
. 2022 Aug;
99(9):e865-e876.
PMID: 36038279
Background And Objectives: Limited data suggest that quantitative MRI (qMRI) measures have potential to be used as trial outcome measures in sporadic inclusion body myositis (sIBM) and as a noninvasive...
9.
Bernabei R, Landi F, Calvani R, Cesari M, Del Signore S, Anker S, et al.
BMJ
. 2022 May;
377:e068788.
PMID: 35545258
Objective: To determine whether a multicomponent intervention based on physical activity with technological support and nutritional counselling prevents mobility disability in older adults with physical frailty and sarcopenia. Design: Evaluator...
10.
Dirnagl U, Duda G, Grainger D, Reinke P, Roubenoff R
Adv Drug Deliv Rev
. 2022 Jan;
182:114118.
PMID: 35066104
Biomedical research accuracy and relevance for improving healthcare are increasingly identified as costly problems. Basic research data quality, reporting and methodology, and reproducibility are common factors implicated in this challenge....